New This Month!
RheumatologyWeb Changes: A Note to Our Members
We are pleased to release a new and improved RheumatologyWeb. Much that has changed will be transparent to you, but you will notice that the login/logout process has been updated (look for your name in the top left corner after you log in). Speaking of your name, please be sure to update your preferences after you log in.
We are most excited about our new content, including two new CME courses that showcase our new CME engine.
We are still in the process of carrying over the content from the previous incarnation of RheumatologyWeb, so you may notice that certain areas of the site are empty. We are working as quickly as possible to bring everything back! In the meantime, make sure you don't miss these:
RHEUMATOLOGYWEB YEAR 2003 IN REVIEW
The past year has been marked by steady progress in our understanding of rheumatic diseases, leading to ever-more efficacious therapeutic strategies. The RheumatologyWeb Editorial Board in conjunction with Tufts University School of Medicine is pleased to present this series of case-based reviews that will help demonstrate recent advances in the treatment of rheumatic conditions. Provides up to 3 credit hours of category 1 credit.
PAINMANAGEMENTWEB YEAR 2003 IN REVIEW
The past year has been marked by striking progress in our understanding of the pathogenesis and underpinnings of pain syndromes, leading to ever-more efficacious therapeutic strategies. The PainManagementWeb Editorial Board in conjunction with Tufts University School of Medicine is pleased to present this series of case-based reviews that will help demonstrate recent advances in the treatment of pain syndromes. Provides up to 3 credit hours of category 1 credit. Offered in cooperation with our sister site PainManagementWeb.
THE SAFETY OF GLUCOSAMINE AND CHONDROITIN IN TYPE 2 DIABETICS
Are glucosamine and chondroitin supplements for osteoarthritis safe in Type 2 diabetics? Yes, Larry Moreland, M.D., reports in this Literature Review, but an upcoming NIH trial will provide definitive answers.
COMPARING INTRAARTICULAR THERAPIE -- CORTICOSTEROIDS VS. HYALURONIC ACID
Are intraarticular steroids equivalent to hyaluronic acid injections for osteoarthritis? Yes, according to a new report, Carlos J. Lozada, M.D., notes in this Literature Review, but study weaknesses still leave the question in doubt.
NEW TRENDS IN RA
A 38-year-old African American woman presents with a four-month history of symmetrical polyarthritis. What are her treatment options? Therapy can include a combination of medications, reports Larry Moreland, M.D., in this Hot Issue, a comprehensive review of recent developments in rheumatoid arthritis.
"IONIZED" WRIST BRACELET
Should physicians pay more attention to the "placebo" effect and make use of it in our practice? Although such an approach goes against our scientific principles, the benefits to patients should not go unnoticed, notes Thomas J. Schnitzer, M.D., Ph.D., in this Literature Review.
ETORICOXIB FOR GOUT
Can a COX-2 inhibitor yield equal benefits - but fewer adverse events - than indomethacin in acute gout attacks? Yes, reports Larry Moreland, M.D., in this Literature Review. But it's not available in the U.S.